Company Profile

Elite Athlete Products Inc
Profile last edited on: 1/25/24      CAGE: 86JD3      UEI: LE1UN7R3MLF5

Business Identifier: Development of NewGait rehab system
Year Founded
2018
First Award
2022
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

4526 Florida Street Unit 6
San Diego, CA 92116
   (319) 321-0117
   N/A
   N/A
Location: Single
Congr. District: 50
County: San Diego

Public Profile

Elite Athlete Products, Inc. (EAP) and their academic partners at Universities of Michigan and qt Wayne State are collaborating to study a post-stroke gait mobility/rehabilitation device. Despite significant advancements in post-stroke medical treatments and rehabilitation interventions, more than 50% of stroke survivors cannot walk independently. Current rehabilitation devices aimed at restoring walking function are either large and unaffordable or ineffective in improving walking function, creating a significant unmet need for a portable, affordable, and effective gait mobility/rehabilitation device. Building on related work already tackled by their associates, the NeuRRo Lab is addressing development of effective and efficient rehabilitation methods for individuals with neurological and orthopedic disorders. “A key issue in stroke rehabilitation is the lack of availability of low-cost, lightweight devices that can be easily taken home to improve therapeutic dosage—an important component for recovery after stroke,” said project lead Dr. Chandramouli Krishnan, Associate Professor of Physical Medicine & Rehabilitation, Michigan Robotics, Biomedical Engineering, and School of Kinesiology. Dr. Krishnan is also a faculty in the U-M Robotics Institute, Michigan Neuroscience Institute, and the University of Michigan-Flint Physical Therapy Department. Most commercial gait rehabilitation systems often require uninterrupted power sources, which is a significant barrier for rural communities in developing nations. Thus, there is a critical need for non-powered technologies for rehabilitation. “The NewGait® system is a natural fit for this need, as it is a non-powered, wearable gait rehabilitation system. Hence, we are interested in exploring this as a method to restore gait function in individuals with stroke,” Dr. Krishnan said. However, the current NewGait® device is not tailored to stroke-specific needs, and the clinical utility has not been verified experimentally. The Phase-I STTR grant will allow EAP to address these gaps by developing a stroke-specific low-cost gait rehabilitation system based on end-user feedback and musculoskeletal modeling. “Our team is uniquely qualified to perform this research, as we have experts in biomedical and mechanical engineering, stroke rehabilitation, biomechanics and modeling, clinical trials research, and human-centered design. We also are working with a world-class rehabilitation hospital,” said Mr. Adeeko, Founder & CEO of EAP. The project team at Michigan Medicine includes Drs. Chandramouli Krishnan (Physical Therapist, Biomechanist, Neuroscientist, and Roboticist), Edward S. Claflin (Physiatrist and Stroke Physician), Claire Kalpakjian (Biopsychosocial Scientist and Clinical and Rehabilitation Psychologist), and Alyssa Portelli (Clinical Physical Therapist). The team also includes Dr. Edward P. Washabaugh (Biomedical Engineer, Biomechanist, and Roboticist), an Assistant Professor in Biomedical Engineering at Wayne State University. Dr. Krishnan hopes that the project will result in a low-cost system for post-stroke gait rehabilitation and will lay the foundation for developing an evidence-based rehabilitation system that could positively affect the lives of millions of stroke survivors across the globe. Mr. Adeeko said, “We are thrilled at the opportunity to further our research efforts on our NewGait line of devices. Funding from this award will allow us to continue development and gather pilot data for a larger clinical study.” The project is funded by NIH NICHD grant R41-HD111289, “NewGait: A Low-Cost Rehabilitation System to Improve Post-Stroke Gait.” The mission of NICHD is “to lead research and training to understand human development, improve reproductive health, enhance the lives of children and adolescents, and opt

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2022 1 NIH $344,843
Project Title: NewGait: a Low-Cost Rehabilitation System to Improve Post-Stroke Gait

Key People / Management

  Olugbenga Adeeko

  Chandramouli Krishnan

Company News

There are no news available.